Onco Wiki / Regimen

Temozolomide monotherapy

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

ComponentsDRUG-TEMOZOLOMIDE
IDREG-TMZ-MONO
TypeRegimen
Statusreviewed 2026-05-07 | pending_clinical_signoff
DiseasesNone declared
SourcesSRC-NCCN-CNS-2025

Notes

Thin regimen stub added to resolve existing GBM temozolomide indication references.

Used By

Indication